Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
Clinical trial NCT00056823 · COMPLETED
Trial details
- NCT number
- NCT00056823
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.